Product Information
CYPROHEPTADINE 4 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0679 per EA under NDC 70710111001. Its NADAC has been published 464 times since Nov 15, 2017.
FDA first approved this application on May 19, 2017. Its Orange Book therapeutic-equivalence code is AA.
Strength
4 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710111001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CYPROHEPTADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208938FDA Approved
5/19/2017
TE Code
AA
On Market Since
7/20/2017
Price Statistics
The NADAC for CYPROHEPTADINE 4 MG TABLET has been published 464 times since Nov 15, 2017, and over the history we have for it it has declined 80.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0679 per EA |
|---|---|
| All-time high | $0.3478 (Nov 15, 2017) |
| All-time low | $0.0644 (Apr 22, 2026) |
| 52-week high | $0.0775 |
| 52-week low | $0.0644 |
| Median price | $0.0968 |
| Average price | $0.1327 |
| Largest weekly change | -25.5% (Jun 23, 2021) |
| Weeks tracked | 464 |
| Tracking since | Nov 15, 2017 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CYPROHEPTADINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CYPROHEPTADINE 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYPROHEPTADINE 4 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0679 per EA (NDC 70710111001), effective Sep 30, 2026.
How has the price of CYPROHEPTADINE 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYPROHEPTADINE 4 MG TABLET has declined 80.5%. It has been tracked across 464 weekly CMS publications since Nov 15, 2017.
What are the highest and lowest recorded NADAC prices for CYPROHEPTADINE 4 MG TABLET?
Since Nov 15, 2017, the NADAC for CYPROHEPTADINE 4 MG TABLET has ranged from a low of $0.0644 (Apr 22, 2026) to a high of $0.3478 (Nov 15, 2017), with a median of $0.0968 per EA.
Are there cheaper alternatives to CYPROHEPTADINE 4 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CYPROHEPTADINE 4 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CYPROHEPTADINE 4 MG TABLET?
CYPROHEPTADINE 4 MG TABLET (NDC 70710111001) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.